NERVGEN PHARMA CORP. Weighted Average Shares
NERVGEN PHARMA CORP. (NGEN) reported Weighted Average Shares of 72.33 million shares for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageShares · last filed 2026-03-31
| Period end | Weighted Average Shares 12 month |
|---|---|
| 2025-12-31 | 72.33M shares 40-F · filed 2026-03-31 |
| 2024-12-31 | 67.32M shares 40-F · filed 2026-03-31 |